Retrograde Technique: High Success Rate in CTO

Original Title: Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.

Reference: Dimitri Karmpaliotis et al. Circ Cardiovasc Interv. 2016 Jun;9(6).

 

Retrograde Technique CTOThis study evaluated the safety and efficacy of the retrograde technique for chronic total occlusions. Researchers compared retrograde vs. anterograde technique outcomes in 1,301 procedures from 11 experienced centers across the US between the years 2012 and 2015.

Population mean age was 65.5±10 years with high diabetes prevalence (45%) and prior MI revascularization surgery (34%).

Globally, technical success was 90%, which reflects the experience of these centers, and major cardiovascular adverse events rate was 2.4%.

The retrograde technique was used in 539 cases (41%), both as initial strategy (46%) and after a failed anterograde attempt (54%).

Comparing both techniques, the retrograde technique was used in more complex cases, both from the clinical (prior surgery 48% vs. 24%; p<0.001) and angiographic point of views (mean Japan CTO score 3.1±1.0 vs 2.1±1.2; p<0.001) and resulted in lower technical success (85% vs. 94%; p<0.001) and higher complications rate (4.3% vs 1.1%; p<0.001).

Multivariable analyzis showed that the presence of suitable collaterals, no prior CABG and the left anterior descending artery as target vessel were success predictors for the retrograde technique.

Conclusion

The retrograde approach is commonly used in the daily contemporary practice especially on most challenging lesions and patients. Despite lower success and higher complications rates compared to the anterograde technique, it is an essential tool to maintain high success rates in chronic total occlusions.

 

We value your opinion. You are more than welcome to leave your comments, thoughts, questions or suggestions here below.

More articles by this author

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...